Weyandt, L., White, T., Gudmundsdottir, B., Nitenson, A., Rathkey, E., De Leon, K., et al. (2018) Neurocognitive, Autonomic, and Mood Effects of Adderall: A Pilot Study of Healthy College Students. Pharmacy, 6, Article 58.
https://doi.org/10.3390/pharmacy6030058

has been cited by the following article:

• TITLE: Efficacy of Photobiomodulation for Attention Deficit Hyperactivity Disorder (ADHD): Case Studies

  AUTHORS: William Stephan, Louis J. Banas, William Brierley, Michael R. Hamblin

  KEYWORDS: Photobiomodulation, Mitochondria, Attention Deficit Hyperactivity Disorder, Low Level Laser Therapy (LLLT), Case Studies

  JOURNAL NAME: World Journal of Neuroscience, Vol.12 No.3, August 16, 2022

  ABSTRACT: Extensive research has now been conducted and published for the treatment of dementia or Alzheimer’s disease, traumatic brain injury (TBI) and other brain disorders using photobiomodulation (PBM), also known as low-level laser therapy (LLLT). However, minimal information is available regarding the use of LLLT for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). We have been using LLLT in our practice for over 15 years addressing chronic pain and injury issues. However, our work with brain injuries is more recent, and we have published three case studies, one describing a serious traumatic brain injury and two describing our success with dementia/Alzheimer’s disease and PTSD. Currently, there is very little published evidence regarding efficacious therapy for ADHD. The case studies presented here, suggest that LLLT can provide alleviation of these symptoms, with some improvement reported after just a single treatment, without any need for pharmaceutical intervention.